Impax Laboratories, Inc.
IPXLtoday announced that Carole Ben-Maimon, M.D., president of
Global Pharmaceuticals, the Company's generic pharmaceutical division, has
resigned for personal and family reasons. Dr. Ben-Maimon's resignation will
be effective November 3, 2014.
Logo - http://photos.prnewswire.com/prnh/20140402/PH96035LOGO
"For more than three years, Carole successfully managed the generic business
by capitalizing on new product launches, advancing our market position, and
expanding and diversifying our portfolio through business development and
M&A opportunities," said Fred Wilkinson, president and CEO of Impax. "We
will continue to benefit from improved business processes established under
Carole. She has served as a great business partner during my short-time at
Impax and her counsel will be missed"
"I am grateful for the relationships and support I have enjoyed over the
past three years at Impax," said Dr. Ben-Maimon. "Impax is a great company,
and I am confident that with its committed employees and under Fred's
leadership, the company will continue to grow and successfully execute its
growth strategy."
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in